ProfileGDS4718 / 223758_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 70% 61% 53% 57% 47% 70% 67% 66% 60% 63% 70% 45% 65% 64% 61% 60% 60% 58% 66% 39% 62% 61% 64% 56% 57% 60% 54% 54% 62% 57% 71% 57% 54% 69% 64% 76% 53% 57% 67% 60% 72% 55% 59% 67% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.828970
GSM549102patient 115, normal, homogenized [OPG study]6.1995461
GSM549104patient 119, normal, homogenized [OPG study]5.6548353
GSM549108patient 138, normal, homogenized [OPG study]5.9695857
GSM549119patient 077, normal, homogenized [OPG study]5.3777347
GSM549133patient 032, cancer, homogenized [OPG study]6.9248870
GSM549139patient 042, cancer, homogenized [OPG study]6.6613767
GSM549099patient 107, normal, homogenized [OPG study]6.530666
GSM549109patient 139, normal, homogenized [OPG study]6.1541560
GSM549110patient 046, normal, homogenized [OPG study]6.3303263
GSM549114patient 063, normal, homogenized [OPG study]6.8268470
GSM549122patient 082, normal, homogenized [OPG study]5.2248845
GSM549134patient 033, cancer, homogenized [OPG study]6.5018465
GSM549136patient 036, cancer, homogenized [OPG study]6.4136664
GSM549140patient 044, cancer, homogenized [OPG study]6.1946761
GSM549111patient 047, normal, homogenized [OPG study]6.1393260
GSM549113patient 057, normal, homogenized [OPG study]6.0922260
GSM549132patient 031, cancer, homogenized [OPG study]5.9670158
GSM549137patient 038, cancer, homogenized [OPG study]6.589266
GSM549142patient 047, cancer, homogenized [OPG study]5.0506939
GSM549100patient 110, normal, homogenized [OPG study]6.2498462
GSM549107patient 135, normal, homogenized [OPG study]6.1867861
GSM549115patient 068, normal, homogenized [OPG study]6.4173464
GSM549116patient 072, normal, homogenized [OPG study]5.838156
GSM549120patient 078, normal, homogenized [OPG study]5.960757
GSM549131patient 030, cancer, homogenized [OPG study]6.1340460
GSM549118patient 074, normal, homogenized [OPG study]5.7500154
GSM549129patient 027, cancer, homogenized [OPG study]5.7451554
GSM549123patient 088, normal, homogenized [OPG study]6.2926562
GSM549124patient 006, cancer, homogenized [OPG study]5.9293557
GSM549126patient 015, cancer, homogenized [OPG study]6.9958771
GSM549128patient 025, cancer, homogenized [OPG study]5.9193757
GSM549103patient 117, normal, homogenized [OPG study]5.7860754
GSM549117patient 073, normal, homogenized [OPG study]6.7590669
GSM549138patient 041, cancer, homogenized [OPG study]6.3924464
GSM549141patient 045, cancer, homogenized [OPG study]7.5525476
GSM549130patient 028, cancer, homogenized [OPG study]5.7091653
GSM549101patient 111, normal, homogenized [OPG study]5.9284257
GSM549105patient 128, normal, homogenized [OPG study]6.659867
GSM549106patient 134, normal, homogenized [OPG study]6.0864860
GSM549112patient 048, normal, homogenized [OPG study]7.0507572
GSM549125patient 011, cancer, homogenized [OPG study]5.8310355
GSM549127patient 024, cancer, homogenized [OPG study]6.097559
GSM549135patient 035, cancer, homogenized [OPG study]6.7104967